Bing Shu , Wang-liang Chen , Jia-lin Song , Shen Fang , Jiong-bang Li , Shang-shi Zhang
{"title":"Synthesis, cytotoxicity study of novel bisacridine derivatives and their interaction with c-myc promoter G-quadruplex/i-motif","authors":"Bing Shu , Wang-liang Chen , Jia-lin Song , Shen Fang , Jiong-bang Li , Shang-shi Zhang","doi":"10.1016/j.jhip.2024.01.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To synthesize novel bisacridine derivatives <strong>A1</strong>-<strong>A4</strong> and study cytotoxicity and their interaction with <em>c-myc</em> G-quadruplex/i-motif DNA.</div></div><div><h3>Method</h3><div>Bisacridines <strong>A1</strong>-<strong>A4</strong> were synthesized according to the conventional reaction method. Fluorescence resonance energy transfer (FRET) melting assay, Surface Plasmon Resonance (SPR) measurement, CD experiments, and molecular docking were used to study the interactions between <strong>A1</strong>-<strong>A4</strong> and <em>c-myc</em> promoter G-quadruplex/i-motif. MTT cytotoxicity assay was used to evaluate the cytotoxicity of the bisacridine derivatives <strong>A1-A4</strong> against A375, Hela, A549, U2OS, HCT116, Siha, HuH7 cell lines.</div></div><div><h3>Result</h3><div>The results of FRET melting assay and SPR measurement indicated that bisacridine derivatives <strong>A1-A4</strong> could bind to and stabilize the <em>c-myc</em> G-quadruplex/i-motif structure. CD experiments and molecular docking results demonstrated the interaction between <strong>A1-A4</strong> and <em>c-myc</em> G-quadruplex/i-motif. MTT experiments showed that <strong>A1-A4</strong> exhibited strong inhibitory effects on the proliferation of human A375, Hela, A549, U2OS, HCT116, Siha, HuH7 cell lines.</div></div><div><h3>Conclusion</h3><div>Bisacridine derivatives <strong>A1-A4</strong> could bind to and stabilize the <em>c-myc</em> G-quadruplex/i-motif to inhibit the proliferation of human cancer cells and will potentially be developed into a class of small molecule ligands targeting <em>c-myc</em> G-quadruplex/i-motif.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"4 4","pages":"Pages 281-286"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Holistic Integrative Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2707368824000037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To synthesize novel bisacridine derivatives A1-A4 and study cytotoxicity and their interaction with c-myc G-quadruplex/i-motif DNA.
Method
Bisacridines A1-A4 were synthesized according to the conventional reaction method. Fluorescence resonance energy transfer (FRET) melting assay, Surface Plasmon Resonance (SPR) measurement, CD experiments, and molecular docking were used to study the interactions between A1-A4 and c-myc promoter G-quadruplex/i-motif. MTT cytotoxicity assay was used to evaluate the cytotoxicity of the bisacridine derivatives A1-A4 against A375, Hela, A549, U2OS, HCT116, Siha, HuH7 cell lines.
Result
The results of FRET melting assay and SPR measurement indicated that bisacridine derivatives A1-A4 could bind to and stabilize the c-myc G-quadruplex/i-motif structure. CD experiments and molecular docking results demonstrated the interaction between A1-A4 and c-myc G-quadruplex/i-motif. MTT experiments showed that A1-A4 exhibited strong inhibitory effects on the proliferation of human A375, Hela, A549, U2OS, HCT116, Siha, HuH7 cell lines.
Conclusion
Bisacridine derivatives A1-A4 could bind to and stabilize the c-myc G-quadruplex/i-motif to inhibit the proliferation of human cancer cells and will potentially be developed into a class of small molecule ligands targeting c-myc G-quadruplex/i-motif.